Cancer-ID: Toward Identification of Cancer by Tumor-Derived Extracellular Vesicles in Blood

Authors :: L. G. Rikkert
P. Beekman
J. Caro
F. A. W. Coumans
A. Enciso-Martinez
G. Jenster
S. Le Gac
W. Lee
T. G. van Leeuwen
G. B. Loozen
A. Nanou
R. Nieuwland
H. L. Offerhaus
C. Otto
D. M. Pegtel
M. C. Piontek
E. van der Pol
L. de Rond
W. H. Roos
R. B. M. Schasfoort
M. H. M. Wauben
H. Zuilhof
L. W. M. M. Terstappen
Source :: Frontiers in Oncology, Vol 10 (2020)
Publication Year :: 2020
Publisher :: Frontiers Media S.A., 2020.
Abstract: Extracellular vesicles (EVs) have great potential as biomarkers since their composition and concentration in biofluids are disease state dependent and their cargo can contain disease-related information. Large tumor-derived EVs (tdEVs, >1 μm) in blood from cancer patients are associated with poor outcome, and changes in their number can be used to monitor therapy effectiveness. Whereas, small tumor-derived EVs (

Subjects :: atomic force microscopy
electrochemistry
electron microscopy
extracellular vesicles
flow cytometry
fluorescence microscopy
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282

Full Text Access

Tools